I think the shorters were trying to push down to close the $1.45 gap, the price was sort of manipulated just before the buyback commencement date.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025